US FTC to hear arguments on motion to dismiss insulin pricing action
MLex Summary: The US Federal Trade Commission has scheduled for Jan. 22 oral arguments on Caremark Rx, Zinc Health Services, Express Scripts, OptumRx and their affiliated group-purchasing organizations’ motion to dismiss...To view the full article, register now.
Already a subscriber? Click here to view full article